ThinkWall

Thinkwall

#HelsinkiUni

Menu
  • ThinkWall
  • Think Corner
  • Sustainability
  • Health
  • Education
  • Nordic Welfare
  • Data
  • Follow HelsinkiUni
  • Search
  • Search
» ThinkWall » ThinkWall

Twiitti käyttäjältä @LifeSciHelsinki

Julkaistu 17.04.2020 klo 08:38

Cerebral dopamine neurotrophic factor CDNF is being tested in phase one and two clinical trials for #Parkinsons Disease treatment: https://t.co/qghls2KdnW @helsinkiuni @BIOTECH_UH @HiLIFE_helsinki #MartSaarma #HelsinkiHealth

— Life Sciences University of Helsinki (@LifeSciHelsinki) April 17, 2020 05:38
Asiasanat Parkinsons MartSaarma HelsinkiHealth
Jaa Twitter Facebook LinkedIn
Read More Arrow
  • About Thinkwall Read More Arrow
  • Contact Information Read More Arrow
  • Follow HelsinkiUni Read More Arrow
© Helsinki University 2015